Calla M. Olson
6Patents
0h-index
12Co-inventors
34Inventor score
Filing activity: Apr 21, 2017 → Dec 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11247991B2 | Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use | Human Necessities | 0 | Active |
| US12318452B2 | Degraders of WEE1 kinase | Human Necessities | 0 | Active |
| US11827636B2 | Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use | Human Necessities | 0 | Active |
| US10865205B2 | Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use | Human Necessities | 0 | Active |
| US10532103B2 | Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US10865204B2 | Degradation of cyclin-dependent kinase 4/6 (CDK4/6) by conjugation of CDK4/6 inhibitors with E3 ligase ligand and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.